CTN NIDA-CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2)
Madhukar H. Trivedi, M.D. Oct 07, 2022
CTN NIDA-CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT)
Walter Ling, M.D. Oct 09, 2020
DTMC NIDA-CTO-0010 Assessment of Potential Interactions Between Methamphetamine and Bupropion
Thomas F. Newton, M.D. May 07, 2018
DTMC NIDA-CTO-0008 Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence
Richard Rawson, Ph.D. May 07, 2018
DTMC NIDA-MDS-0007 Phase 2, Double-Blind, Placebo-Controlled Trial Of Bupropion For Methamphetamine Dependence
Ann Anderson, M.D. Dec 04, 2014
CTN NIDA-CTN-0046 Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
T. John Winhusen, Ph.D. , Eugene Somoza, M.D. Nov 19, 2013
